Concepedia

Poornima Shubhakar

PS

Statistics

Publications

3

Citations

119

H-Index

3

Active since

2008

Affiliations

Amgen (United States)(Current)

Poornima Shubhakar is an author at Amgen (United States) specializing in pharmacokinetics of monoclonal antibodies, pharmacology, and oncology.

Publications per year

2008–2012

3

Publications

3

A Phase Ib Study of AMG 102 in Combination with Bevacizumab or Motesanib in Patients with Advanced Solid Tumors

Peter J. Rosen, Christopher J. Sweeney, Dorothy J. Park et al. · Clinical Cancer Research · 2010 · 69 citations

, , +16

Safety and Pharmacokinetics of Ganitumab (AMG 479) Combined with Sorafenib, Panitumumab, Erlotinib, or Gemcitabine in Patients with Advanced Solid Tumors

Lee S. Rosen, Igor Puzanov, Gregory Friberg et al. · Clinical Cancer Research · 2012 · 34 citations · Full text

, , +17

AMG 102, an HGF/SF antagonist, in combination with anti-angiogenesis targeted therapies in adult patients with advanced solid tumors

Peter J. Rosen, Chris Sweeney, D. J. Park et al. · Journal of Clinical Oncology · 2008 · 16 citations

, , +17

1–3 of 3